P3 Health Partners (PIII)
(Delayed Data from NSDQ)
$0.50 USD
0.00 (0.14%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $0.49 -0.01 (-2.91%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for P3 Health Partners Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 41 | 18 | 141 | 0 | 0 |
Receivables | 121 | 80 | 52 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 3 | 7 | 0 | 0 |
Total Current Assets | 166 | 101 | 200 | 0 | 0 |
Net Property & Equipment | 9 | 9 | 8 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 4 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 667 | 751 | 2,146 | 0 | 0 |
Deposits & Other Assets | 20 | 16 | 0 | 0 | 0 |
Total Assets | 861 | 877 | 2,364 | 0 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 26 | 0 | 0 | 0 |
Accounts Payable | 222 | 176 | 142 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 4 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 64 | 39 | 15 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 14 | 0 | 38 | 0 | 0 |
Total Current Liabilities | 299 | 242 | 199 | 0 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 108 | 94 | 80 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 6 | 6 | 15 | 0 | 0 |
Minority Interest (Liabilities) | 292 | 517 | 1,791 | 0 | 0 |
Total Liabilities | 719 | 871 | 2,091 | 0 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 509 | 315 | 313 | 0 | 0 |
Retained Earnings | -367 | -310 | -39 | 0 | 0 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 142 | 6 | 274 | 0 | 0 |
Total Liabilities & Shareholder's Equity | 861 | 877 | 2,364 | 0 | 0 |
Total Common Equity | 142 | 6 | 274 | 0 | 0 |
Shares Outstanding | 313.10 | 40.30 | 40.30 | 7.90 | NA |
Book Value Per Share | 0.45 | 0.15 | 6.79 | 0.00 | 0.00 |
Fiscal Year End for P3 Health Partners Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 78 | 32 | 41 | 57 | 66 |
Receivables | 155 | 144 | 121 | 119 | 104 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 8 | 7 | 4 | 3 | 2 |
Total Current Assets | 242 | 183 | 166 | 180 | 172 |
Net Property & Equipment | 8 | 8 | 9 | 9 | 10 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 625 | 646 | 667 | 688 | 709 |
Deposits & Other Assets | 18 | 19 | 20 | 20 | 18 |
Total Assets | 893 | 856 | 861 | 897 | 909 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 265 | 256 | 222 | 203 | 175 |
Current Portion Long-Term Debt | 1 | 1 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 76 | 62 | 64 | 48 | 46 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 11 | 15 | 14 | 17 | 30 |
Total Current Liabilities | 352 | 334 | 299 | 267 | 250 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 133 | 118 | 108 | 108 | 108 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 30 | 6 | 7 | 8 | |
Minority Interest (Liabilities) | 198 | 239 | 292 | 313 | 667 |
Total Liabilities | 726 | 709 | 719 | 709 | 1,045 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 565 | 533 | 509 | 530 | 192 |
Retained Earnings | -398 | -386 | -367 | -342 | -329 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 167 | 147 | 142 | 188 | -136 |
Total Liabilities & Shareholder's Equity | 893 | 856 | 861 | 897 | 909 |
Total Common Equity | 167 | 147 | 142 | 188 | -136 |
Shares Outstanding | 357.70 | 315.90 | 313.10 | 312.60 | 312.60 |
Book Value Per Share | 0.47 | 0.46 | 0.45 | 0.60 | -0.44 |